Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Biocon Limited ( (IN:BIOCON) ) is now available.
Biocon Limited’s board has approved a plan to raise up to ₹4,500 crores through various financial instruments, subject to necessary approvals. Additionally, the company plans to increase its authorized share capital to ₹7,00,00,00,000, with amendments to its Memorandum of Association, pending shareholder and regulatory approvals.
More about Biocon Limited
Biocon Limited is a biopharmaceutical company based in Bangalore, India. It specializes in the development and production of generic active pharmaceutical ingredients (APIs) and biosimilars, focusing on providing affordable healthcare solutions globally.
YTD Price Performance: -9.45%
Average Trading Volume: 134,391
Current Market Cap: 400.9B INR
See more insights into BIOCON stock on TipRanks’ Stock Analysis page.